iShares Genomics Immunology and Healthcare ETF
IDNA
66 hedge funds and large institutions have $36.1M invested in iShares Genomics Immunology and Healthcare ETF in 2023 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 22 reducing their positions, and 10 closing their positions.
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
1% less funds holding
Funds holding: 67 → 66 (-1)
4.22% less ownership
Funds ownership: 33.57% → 29.35% (-4.2%)
25% less capital invested
Capital invested by funds: $47.9M → $36.1M (-$11.8M)
32% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$2.33M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$467K |
| 3 |
WBG
Wharton Business Group
Malvern,
Pennsylvania
|
+$449K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$346K |
| 5 |
SFFS
Stonehage Fleming Financial Services
St. Helier,
Jersey
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WAP
Wealthcare Advisory Partners
West Chester,
Pennsylvania
|
-$3.89M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$3.04M |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$924K |
| 4 |
Morgan Stanley
New York
|
-$874K |
| 5 |
MFA
Mayflower Financial Advisors
Boston,
Massachusetts
|
-$648K |
IDNA Hedge Fund Activity: Q3 2023 in Review
66 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2023, worth a combined $36.1M — down 25% from $47.9M a quarter earlier.
Fund positioning in IDNA was balanced in Q3 2023: 10 funds opened new positions, 10 closed out, 15 added to existing stakes and 22 trimmed.
The largest buyer was Jane Street, adding an estimated $2.33M. The largest seller was Wealthcare Advisory Partners, cutting an estimated $3.89M.
- 66 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2023, down from 67 in Q2 2023.
- Funds reported $36.1M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2023, down 25% quarter-over-quarter.
- 10 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2023 and 10 closed out, a net change of 0 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2023 was Jane Street, an estimated $2.33M added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2023 was Wealthcare Advisory Partners, an estimated $3.89M sold.
Based on aggregated 13F filings for Q3 2023.